1. Cambridge, Mass.-based Ariad Pharmaceuticals recently earned marketing approval and a label expansion for its Leukemia drug Iclusig.
2. Clobestasol propionate lotion, developed by Buena, N.J.-based Teligent, is intended to treat skin conditions like eczema and psoriasis.
3. Baltimore-based Lupin Pharmaceuticals developed armodafinil tablets, which are intended to improve wakefulness in adults with excessive sleepiness.
4. The ConvertX Nephroureteral Stent System, developed by Mountain View, Calif.-based BrightWater Medical, is intended to treat patients with ureteral obstructions.
5. Philadelphia-based Lannett created metaxalone tablets — a muscle relaxant for patients with acute, painful musculoskeletal conditions.
More articles on supply chain:
Spearheading a first-of-its-kind logistics center: 5 questions with Dennis Mullins, VP of supply chain for IU Health
Trump picks Elaine Chao for transportation secretary: 7 things to know
How Amazon trains new warehouse workers in just 2 days
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.